Answer Questions About Biosimilars

January 2020

You'll see use of biosimilars continue to expand.

Truxima (rituximab-abbs) is the first available biosimilar for Rituxan...and Mvasi (bevacizumab-awwb) is the first for Avastin.

More biosimilars will be accessible for these meds and others, such as Herceptin (trastuzumab).

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote